Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.36
Delayed Data
As of Feb 22
 -0.47 / -0.76%
Today’s Change
53.74
Today|||52-Week Range
68.12
-2.01%
Year-to-Date

Today’s Trading

Previous close61.83
Today’s open61.72
Day’s range61.30 - 61.95
Volume6,413,596
Average volume (3 months)7,751,961
Market cap$98.6B
Dividend yield4.17%
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.00%
Earnings growth (next 5 years)+12.20%
Revenue growth (last year)+12.16%
P/E ratio16.6
Price/Sales3.98
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.60-1.44%
CELGCelgene-0.17-0.14%
AGNAllergan-0.84-0.34%
BMYBristol-Myers Squibb+0.57+1.04%
Data as of 4:02pm ET, 02/22/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$1.26
Annual revenue (last year)$25.6B
Annual profit (last year)$6.0B
Net profit margin23.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts


Search for Jobs